nChroma Analysis: $75M Raised
What is nChroma?
nChroma Bio develops genetic medicines using programmable in vivo delivery systems tailored to specific diseases. The company combines advanced genetic cargos with targeted delivery technologies to create durable treatments addressing high unmet medical needs. Their approach is guided by biological insights to inform therapeutic design.
Location
201 Brookline Ave, Boston, Massachusetts 02215, United States
Employees
51-200
Founded
2024
Funding Status
Seed
Product Features & Capabilities
- Programmable in vivo delivery systems
- Tailored genetic medicines
- Cell-specific delivery technologies
Use Cases
Develop treatments for genetic disorders; Target specific biological drivers of diseases; Address unmet medical needs in therapeutics; Create durable genetic therapies; Utilize advanced delivery technologies for precision medicine
See something that needs updating? Suggest edits to this profile.